2020
DOI: 10.1007/s10072-020-04716-8
|View full text |Cite
|
Sign up to set email alerts
|

Economic burden of medication-overuse headache in Iran: direct and indirect costs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 21 publications
0
11
0
Order By: Relevance
“…Although overall this was only 1.1%, what is of concern is the strong association with age, with AOR = 5.0 in adolescents (prevalence 1.9%) compared with children (prevalence 0.4%) (Table 2). Thus is the pattern set for MOH in adults, a significant and costly cause of disability in Iran (16). MOH is an acquired disorder, attributable to a behaviour that, when it occurs in children, is most probably taught to them by their parents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although overall this was only 1.1%, what is of concern is the strong association with age, with AOR = 5.0 in adolescents (prevalence 1.9%) compared with children (prevalence 0.4%) (Table 2). Thus is the pattern set for MOH in adults, a significant and costly cause of disability in Iran (16). MOH is an acquired disorder, attributable to a behaviour that, when it occurs in children, is most probably taught to them by their parents.…”
Section: Discussionmentioning
confidence: 99%
“…It is the first such study from the Eastern Mediterranean Region, adding to those from European (8,9), Western Pacific (10) and African Regions (11,12). While there is published evidence of headache-attributed burden among adults in Iran, the data are not population-based (14 16). Iran is the second-largest country in the Middle East after Saudi Arabia, although much of it is mountainous and uninhabitable.…”
Section: Introductionmentioning
confidence: 99%
“…The 3-month cost per patient with MOH fell from EUR 2989 to EUR 1160 in Italy [95]. Moreover, the total cost for MOH patients is USD 10,179,000,000 annually in Iran [96]. A high economic burden for MOH was shown in other countries in the world as well [46,[97][98][99].…”
Section: Discussionmentioning
confidence: 99%
“…In this research, each dollar was considered equal to currency exchange rate at the time of payments as 42 000 Rials. 19 Inclusion/Exclusion Criteria All data of the survivors exposed to SM were included. Only the HCU of survivors was examined and the data of their families were excluded from the study.…”
Section: Methodsmentioning
confidence: 99%